Ypsomed Holding AG

General ticker "YPHDF" information:

  • Sector: Health Care
  • Industry: Medical - Instruments & Supplies
  • Capitalization: $5.7B (TTM average)

Ypsomed Holding AG does not follow the US Stock Market performance with the rate: -28.2%.

Estimated limits based on current volatility of -0.2%: low 355.19$, high 353.74$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-07-07, amount 1.39$ (Y0.39%)
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

  • 2025-03-31 to 2026-03-31 estimated range: [328.01$, 517.72$]
  • 2026-03-31 to 2027-03-31 estimated range: [315.04$, 501.36$]

Similar symbols

Short-term YPHDF quotes

Long-term YPHDF plot with estimates

Financial data

YTD 2024-03-31 2025-03-31 2026-03-31
Operating Revenue CHF548.46MM CHF748.87MM CHF730.98MM
Operating Expenses CHF462.24MM CHF636.01MM CHF484.91MM
Operating Income CHF86.22MM CHF112.85MM CHF246.07MM
Non-Operating Income CHF-4.35MM CHF-8.54MM CHF-5.11MM
Interest Expense CHF5.04MM CHF6.64MM CHF3.18MM
R&D Expense CHF0.00MM CHF33.55MM CHF40.02MM
Income(Loss) CHF81.87MM CHF104.31MM CHF240.97MM
Taxes CHF3.51MM CHF16.81MM CHF19.04MM
Net Income(Loss)* CHF78.37MM CHF87.50MM CHF221.93MM
Stockholders Equity CHF617.73MM CHF679.68MM CHF748.13MM
Inventory CHF75.29MM CHF85.75MM CHF60.61MM
Assets CHF1,101.39MM CHF1,330.34MM CHF1,346.60MM
Operating Cash Flow CHF163.22MM CHF148.20MM CHF306.76MM
Capital expenditure CHF195.31MM CHF277.15MM CHF323.10MM
Investing Cash Flow CHF-195.07MM CHF-267.27MM CHF-27.49MM
Financing Cash Flow CHF81.07MM CHF82.25MM CHF-286.45MM
Earnings Per Share** CHF5.74 CHF6.41 CHF16.31

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.